Literature DB >> 9721395

Pneumococcal vaccine administration associated with splenectomy: missed opportunities.

E A Kind1, C Craft, J B Fowles, C E McCoy.   

Abstract

BACKGROUND: The spleen defends against infection from encapsulated organisms. Patients who have had splenectomies are at risk for the development of overwhelming pneumococcal infections. Guidelines recommend that pneumococcal vaccine be given to all patients who have splenectomies.
METHODS: This retrospective study was performed to evaluate compliance with the guidelines in patients from a large multispecialty group practice who had splenectomies between 1988 and 1991. Ninety-five patients were identified, and their clinic and hospital records were reviewed.
RESULTS: Overall, 73.7% of patients who had splenectomies received the pneumococcal vaccine. No significant differences were found in the vaccination rates over time or among the surgeons.
CONCLUSIONS: Improvement is needed in ensuring that patients who have splenectomies receive pneumococcal vaccine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721395     DOI: 10.1016/s0196-6553(98)70038-0

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  4 in total

1.  Prevention of infection post-splenectomy: time for implementation of guidelines.

Authors:  B O'Connell
Journal:  Ir J Med Sci       Date:  2004 Jul-Sep       Impact factor: 1.568

2.  Vaccination coverage in adults undergoing splenectomy: evaluation of hospital vaccination policies.

Authors:  L Bruni; J M Bayas; A Vilella; A Conesa
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

3.  Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed.

Authors:  D J Waghorn
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 4.  Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review.

Authors:  Shannon E MacDonald; Airlie Palichuk; Linda Slater; Hailey Tripp; Laura Reifferscheid; Catherine Burton
Journal:  Hum Vaccin Immunother       Date:  2021-07-16       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.